My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Seres Therapeutics, Inc. - Common Stock (NQ:MCRB)

20.16 -1.48 (-6.84%)

Streaming Delayed Price Updated: 10:06 AM EST, Nov 18, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Seres Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Seres (MCRB) Q3 2025 Earnings Call Transcript ↗

November 05, 2025

Seres (MCRB) Q3 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Earnings Scheduled For November 5, 2025 ↗

November 05, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

November 03, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

September 08, 2025

Via Benzinga

Top movers in Monday's pre-market session ↗

September 08, 2025

The US market is yet to commence its session on Monday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.

Via Chartmill

Earnings Scheduled For August 6, 2025 ↗

August 06, 2025

Via Benzinga

Earnings Scheduled For May 7, 2025 ↗

May 07, 2025

Via Benzinga

Earnings Scheduled For November 13, 2024 ↗

November 13, 2024

Via Benzinga

What's Next: Seres Therapeutics's Earnings Preview ↗

November 12, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

September 08, 2025

Via Benzinga

Why Robinhood Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket ↗

September 08, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

August 08, 2025

Via Benzinga

Seres (MCRB) Q2 Loss Narrows 34% ↗

August 06, 2025

Via The Motley Fool

Seres Therapeutics Inc (NASDAQ:MCRB) Reports Q2 2025 Earnings: Narrower EPS Loss but Shares Dip in Pre-Market ↗

August 06, 2025

Seres Therapeutics reports Q2 2025 results with $0.0 revenue and a narrower EPS loss of $2.27, beating estimates. Shares dip 4.5% pre-market despite recent 23% gain. Progress noted in SER-155 clinical...

Via Chartmill

Uncovering Potential: Seres Therapeutics's Earnings Preview ↗

August 05, 2025

Via Benzinga

This Coty Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday ↗

May 08, 2025

Via Benzinga

Uber To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Thursday ↗

May 08, 2025

Via Benzinga

Quest Diagnostics Posts Better-Than-Expected Earnings, Joins Pentair, 3M, Danaher And Other Big Stocks Moving Higher On Tuesday ↗

April 22, 2025

Via Benzinga

Stay updated with the stocks that are on the move in today's pre-market session. ↗

April 15, 2025

Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Via Chartmill

Stay updated with the stocks that are on the move in today's after-hours session. ↗

April 14, 2025

As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.

Via Chartmill

12 Health Care Stocks Moving In Monday's After-Market Session ↗

April 14, 2025

Via Benzinga

Earnings Scheduled For March 13, 2025 ↗

March 13, 2025

Via Benzinga

What's going on in today's after hours session ↗

March 12, 2025

Discover the top movers in Wednesday's after-hours session and stay informed about the post-market dynamics.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

March 12, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

January 16, 2025

Via Benzinga

This Verizon Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday ↗

October 24, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

September 26, 2024

Via Benzinga

MCRB Stock Earnings: Seres Therapeutics Beats EPS for Q2 2024 ↗

August 13, 2024

MCRB stock results show that Seres Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's Intraday Session ↗

June 10, 2024

Via Benzinga

Why GameStop Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

June 07, 2024

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.